Advertisement

Topics

FDA receives reports of serious adverse events after triamcinolone, moxifloxacin compound injections

10:43 EDT 31 Jul 2017 | Healio

The FDA is warning clinicians about serious adverse events reported after intravitreal injections of triamcinolone and moxifloxacin compounded by Guardian Pharmacy Services in Dallas.At least 43 patients at two Dallas surgery centers experienced serious adverse effects after receiving the injection following cataract surgery. The FDA received the adverse event reports on April 5 and June 1.

Original Article: FDA receives reports of serious adverse events after triamcinolone, moxifloxacin compound injections

NEXT ARTICLE

More From BioPortfolio on "FDA receives reports of serious adverse events after triamcinolone, moxifloxacin compound injections"

Quick Search
Advertisement
 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...